PJC
CVS icon

Phillip James Consulting’s CVS Health CVS Stock Holding History

Phillip James Consulting’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Hold
11
– – ﹤0.01% 259
2026
Q1 		$1K Buy
+11
New +$847 ﹤0.01% 273

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Phillip James Consulting's CVS Position: Q2 2026 in Review

Phillip James Consulting held its CVS Health (CVS) position steady in Q2 2026 at 11 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #259.

Phillip James Consulting first reported a position in CVS in Q1 2026 and has held it in 2 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Phillip James Consulting held 11 shares of CVS Health worth $1.14K as of Q2 2026.
  • Phillip James Consulting left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up ﹤0.01% of Phillip James Consulting's portfolio in Q2 2026, its #259 holding.
  • Phillip James Consulting first reported a position in CVS Health in Q1 2026 and has held it in 2 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.